Integrated prostate cancer care: efficiency, accuracy and confidence at every stage

Diagnosing prostate cancer is not always straightforward. The key challenge lies in accurately distinguishing between slow-growing cancers that may never cause harm and more aggressive forms of the disease that require timely treatment, ensuring that patients receive the right treatment at the right time.

DynaCAD Prostate with Quibim AI-powered^*,1,2 automation improves radiology workflow efficiencies, while UroNav enables MRI–ultrasound fusion-guided biopsy. Philips IntelliSite Pathology Solution with IBEX AI³ further enhances diagnostic consistency and scalability. By integrating data within DynaCAD Urology, clinicians gain a unified patient view to support diagnosis and personalized treatment selection, while the same UroNav image-guided enables planning and guidance of personalized, focal therapy. By streamlining workflows, Philips helps hospitals deliver higher-quality prostate cancer care.

As healthcare systems continue their shift toward value-based care, prostate cancer represents a critical opportunity to improve outcomes while controlling costs. Precision diagnostics, AI-enabled workflow automation, and targeted therapies allow hospitals to move beyond one-size-fits-all approaches toward more efficient and personalized care models. Through its integrated prostate cancer portfolio, Philips empowers hospitals to detect the right cancer, treat the right patient, avoid unnecessary procedures, improve quality of life, and sustainably manage costs across the continuum of care.

This is not only a technology investment, but a strategic step toward smarter, more resilient prostate cancer care.